Screener
Amgen AMGN Unrealized Gains on Investments
Unrealized Gains on Investments at other companies
Other financials
Where this comes from
Reported directly by Amgen in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.
The source filing: Amgen’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000318154-26-000126
| Types of securities as of June 30, 2026 | Amortizedcost | Grossunrealizedgains | Grossunrealizedlosses | Fairvalues |
|---|---|---|---|---|
| U.S. Treasury bills | $2,493 | — | — | $2,493 |
| Money market mutual funds | 10,793 | — | — | 10,793 |
| Other short-term interest-bearing securities | 129 | — | — | 129 |
| Total interest-bearing securities | $13,415 | — | — | $13,415 |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is Amgen's unrealized gains on investments?
- Amgen (AMGN) reported unrealized gains on investments of $0 in Q2 2026.
- What is the long-term trend for Amgen's unrealized gains on investments?
- Over 5 years (2020 to 2025), Amgen's unrealized gains on investments has grown at a -100.0% compound annual growth rate (CAGR), from $1M to $0.
- What does unrealized gains on investments mean?
- The total unrealized gains on investments, typically related to available-for-sale securities.
Ask your AI about Amgen's unrealized gains on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude